We therefore investigated in a preclinical “humanized mouse model of Duchenne muscular dystrophy” (mdx/mTRG2 mice) [26,27], the effects of the novel sGC stimulator, BAY-747. The gene discussed is SGCB; the disease is Duchenne muscular dystrophy.